In this hallmark episode #70 of LetsTalkValue, Dr Clifford Hudis shares his views both as a leading clinician in oncology as well as the lead executive of the largest professional oncology society.
In discussion with Dr Verena Voelter, he discusses the highlight of this year's annual meeting: the breakthrough of targeting RAS mutations now becoming a reality after decades of search. It was possible through creativity, commitment, resilience, and a shared vision among a truly 5P environment of dedicated scientists, clinicians, public funding sources, private drug development companies and patients. Dr Hudis is very positive about the ultimate potential of AI for the future of delivering value to patients to feel and live better with cancer. In his concluding remarks he speaks about enouraging the next generation of MD entrepreneurs to embrace leadership and training possibilities. Not to be missed episode as truely uplifting in an era of challenging news sometimes.